SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001659617-18-000109
Filing Date
2018-11-13
Accepted
2018-11-13 07:17:14
Documents
55
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mbx-20180930.htm   iXBRL 10-Q 1184621
2 EXHIBIT 31.1 a2018q3ex311-xnextgen.htm EX-31.1 11483
3 EXHIBIT 31.2 a2018q3ex312-xnextgen.htm EX-31.2 11185
4 EXHIBIT 32.1 a2018q3ex321-xnextgen.htm EX-32.1 7591
5 EXHIBIT 32.2 a2018q3ex322-xnextgen.htm EX-32.2 7393
11 mbx-20180930_g1.jpg GRAPHIC 12313
  Complete submission text file 0001659617-18-000109.txt   5735114

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mbx-20180930.xsd EX-101.SCH 46776
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mbx-20180930_cal.xml EX-101.CAL 49841
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mbx-20180930_def.xml EX-101.DEF 217382
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mbx-20180930_lab.xml EX-101.LAB 485340
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mbx-20180930_pre.xml EX-101.PRE 334353
12 EXTRACTED XBRL INSTANCE DOCUMENT mbx-20180930_htm.xml XML 1013726
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 181175066
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1